FORMULATIONS AND DOSAGES FOR ADMINISTERING A COMPOUND THAT INHIBITS MCL1 PROTEIN

Formulations of compounds of Formula I are provided as are doses and dosing regimens useful in methods of treating cancer including hematological malignances such as acute myelogenous leukemia, multiple myeloma, and non-Hodgkin's lymphoma. L'invention concerne des formulations de composés...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LA, STEVEDAT K, KELLY, RON C, KENNEDY, MICHAEL T
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Formulations of compounds of Formula I are provided as are doses and dosing regimens useful in methods of treating cancer including hematological malignances such as acute myelogenous leukemia, multiple myeloma, and non-Hodgkin's lymphoma. L'invention concerne des formulations de composés de formule I qui sont des doses et des schémas posologiques utiles dans des méthodes de traitement de cancer, notamment des malignités hématologiques telles que la leucémie myéloïde aiguë, le myélome multiple et le lymphome non hodgkinien. [INSÉRER LE COMPOSÉ ICI]